Introduction
Cytokines are a diverse family of small, secreted glycoproteins that performs multiple functions, including growth regulation, differentiation, and cell proliferation (Tyson et al., 2001) . Hematopoietic cytokines are one of the important groups involved in both hematopoietic and nonhematopoietic cell regulation and differentiation (Bazan, 1991) . Among all the hematopoietic cytokines, erythropoietin (EPO) is an essential cytokine necessary for the differentiation, proliferation, and maintenance of stem cells that produce red blood cells (Jelkmann, 1992a (Jelkmann, , 2011b . EPO action is mediated through its binding to a specific cell membrane receptor, known as an erythropoietin receptor (EPO-R) (Lodish et al., 1995) . EPO-R is a member of the hematopoietic cytokine receptor superfamily and consists of an intracellular, a transmembrane, and an extracellular EPO-binding domain (D' Andrea et al., 1991) .
Studies on the EPO receptor are still of a larger interest after the findings that the EPO-R is expressed not only in hematopoietic but also in nonhematopoietic cells and tissues (Farrell and Lee, 2004) . Early studies on EPO-R showed that this receptor is only expressed in cells of the erythroid lineage, emphasizing that the action of EPO is limited to red blood cell manufacturing, while further studies divulged the wide expression of the EPO-R, increasing the likelihood of extra-hematopoietic effect of EPO (Wang et al., 2014) . The detection of EPO-R mRNA in the brain, heart, retinal, skeletal, muscle, and kidney cells makes it a promising target to study its untold functions (Morishita et al., 1997; Wu et al., 1999; Noguchi et al., 2008; Hu et al., 2013) .
Defining the exact function of a protein, especially with multifunctional behavior, is not easy in vivo due to the occurrence of numerous other interacting molecules. Detailed knowledge of the 3D structure of a protein is essential for the proper understanding of the biological function(s) of protein (Bork and Koonin, 1998; Attwood, 2000) . Several posttranslation modifications (PTMs), e.g., N-or O-glycosylation, acetylation, sulfation, methylation, and phosphorylation, could modify the 3D structure of a protein. Among all PTMs, O-linked phosphorylation and glycosylation of serine/threonine (Ser/Thr) residues of a protein are extremely dynamic and help in modulating the function of proteins by temporarily affecting their 3D structure ( Figure 1A) .
Alternating O-glycosylation and phosphorylation and their interplay at the same or neighboring residues are known as the yin-yang phenomenon (Wells et al., 2004) . The amino acid residues (Ser/Thr) where this interplay occurs are termed as yin-yang sites. These yin-yang sites can be predicted reliably using various programs based on artificial neural networks. However, conserved sites with high phosphorylation and low O-glycosylation are considered false negative yin-yang sites. This alternating phosphorylation and O-glycosylation phenomenon has been observed in many different proteins that influence the localization, folding, solubility, biological half-life, antigenicity, and cell-to-cell interaction of the protein (Love and Hanover, 2005; Jahangir et al., 2014; Wang et al., 2016) .
Ligand-induced intracellular phosphorylation of the EPO-R is an experimentally proven phenomenon that plays an important role in the regulation of hematopoietic and nonhematopoietic downstream signaling pathways (Sawyer and Penta, 1996; Elliott et al., 2006; FunakoshiTago et al., 2016) . The intention for selecting the EPO-R as a model protein for this study was to involve this receptor in mediating multiple effects by its single ligand. This study was conducted to reveal the behavior of EPO as a multifunctional protein, based on the modification potential of its receptor, particularly concerning alternating O-glycosylation and phosphorylation at Ser, Thr, and tyrosine (Tyr) residues.
In the present study, how these two PTMs that might affect the functions of EPO-R was examined. There may be a direct or reciprocal interplay between O-glycosylation and phosphorylation at Ser/Thr residues that modulates the function of EPO receptor. Previously, it was considered that only O-glycosylation modifications at Ser/Thr residues have any association with phosphorylation on the same residues. However, in this study, the role of a newly identified phenomenon in which Tyr phosphorylation also interacts with O-glycosylation (Ande et al., 2009) was discussed ( Figure 1B) . Furthermore, the presence of certain favorable or nonfavorable amino acids around the Ser/Thr residues of EPO-R that may affect the glycosylation potential of these residues was also discussed. 
Materials and methods

Sequences retrieval and selection
For the prediction of yin-yang sites, O-glycosylation, and phosphorylation modification of human EPO-R, the sequence was obtained from the Swiss-Prot sequence database with the entry name of EPOR_HUMAN (accession number NP_000112). To select the orthologs of EPO-R gene, a BLAST search was performed using the human EPO-R sequence as a reference. The NCBI-BLAST database was used with all default parameters. From the obtained search results, five mammal sequences with high similarity indexes were selected. The selected sequences were: Sus scrofa (wild boar), Canis lupus (domestic dog), Mus musculus (house mouse), Rattus norvegicus (brown rat), and Macaca mulatta (rhesus monkey) ( Table 1) . ClustalW software was used to locate the position of conserved Ser/Thr and Tyr residues among the mammalian EPO-R protein sequences (Thompson et al., 1994) .
Phosphorylation prediction method
For prediction of phosphorylation sites in human EPO-R, Netphos 2.0 (http://www.cbs.dtu.dk/services/NetPhos-2.0/ or http://www.cbs.dtu.dk/services/NetPhos) was used. The threshold value used to predict phosphorylation was 0.5. This software retrieves the data of protein phosphorylation modification through phosphoBase 2.0 (Kreegipuu et al., 1999; Huang et al., 2005) . These methods are based on artificial neural networks that consist of a large number of interconnected processing nodes (neurons) that receive numerous inputs and give a single output generated on the strengths of multiple inputs (Kreegipuu et al., 1999) . For the prediction of kinase potential to phosphorylate Ser, Thr, and Tyr residues of human EPO-receptor, the NetphosK 1.0 (http://www.cbs.dtu.dk/services/NetPhosK/) and KinasePhos 2.0 (http://kinasephos2.mbc.nctu.edu.tw/) servers were used. Computer-based methods predict the PTM potential of amino acids under the perspective for regulation of protein with reliable accuracy (Nielsen et al., 1999) .
Prediction of yin-yang and O-glycosylation sites of human EPO-R
The potential of human EPO-R for the presence of yin-yang and O-glycosylation sites was measured through YinOYang 1.2 (http://www.cbs.dtu.dk/services/YinOYang/) software. This software also employs a panel of neural networks to experimentally determine O-glycosylation attachment sites by recognizing the amino acid sequence context and surface accessibility of kinases to these sites. The threshold value used by this software varies depending on the accessibility of amino acid residues to the surface of protein (Gupta et al., 1999) . The YinOYang 1.2 prediction technique was 72.5% efficient for glycosylated sites and 79.5% efficient for nonglycosylated site in a validation test, verifying the correlation coefficient of Matthews: 0.22 on the original data, and 0.84 on the amplified data set (Matthews, 1975) .
Results
Yin-yang and of O-glycosylation predicted sites of
human EPO-R YinOYang 1.2 prediction outcome showed that human EPO-R contains 19 amino acids having potential for O-glycosylation modification, and five amino acids that may serve as potential yin-yang sites (Table 2; Figure 2 ). Out of these five yin-yang sites, three were predicted in the extracellular domain, while two sites were predicted in the cytoplasmic domain of EPO-R ( Figure 3 ). The cytoplasmic domain is catalytically more important, as it serves as a docking site for proteins involved in the signaling cascade triggered by erythropoietin. More glycosylation and phosphorylation sites were predicted in this domain and might have some significance in modulating the function of EPO-R. We propose that these predicted yin-yang sites have an alternate interaction with phosphorylation and O-glycosylation on the same and neighboring residues, which might contribute significantly in exerting different effects of EPO on different tissues. 
False negative yin-yang sites in human EPO-R
A conserved site with high phosphorylation but low O-glycosylation potential (close to the threshold value) is considered a false negative yin-yang site. The reason for considering these sites false negative is that if a kinase enzyme could access them, then there is a possibility that glycosylation enzymes also access these sites (Kamemura et al., 2002) . In EPO-R, 13 Ser and 4 Thr residues seemed to be false negative yin-yang positions (Table 2) , as these residues showed a potential for O-glycosylation very close to threshold value and a high potential for phosphorylation modification. These false-negative yin-yang residues were also conserved in most mammalian species (Figure 4 ).
Predicted phosphorylation sites of human EPO-R
Phosphorylation prediction results indicate that human EPO-R has high potential for phosphorylation ( Figure 2B ). A total of 34 amino acids were predicted to be modified through phosphorylation and among these 34 amino acids 20 were Ser, 9 were Thr, and 5 were Tyr (Table 3 ). There are eight reported Tyr phosphorylation sites in EPO-R (Klingmuller, 1997) . Among these 8 Tyr phosphorylation sites, 5 sites (Y343, Y401, Y443, Y461, and Y464) were predicted correctly but 3 sites (Y429, Y431, and Y479) were not predicted for phosphorylation by YingOYang 1.2. Netphos 2.0 predicted 34 possible phosphorylation sites, and out of these 34 sites 15 are fully conserved and 90, 103, 160, 212, 357, 376, 379, 380, 382, 383, 444, 478, 483 Ser 160, 380, 444 Ser 151, 183, 221, 248, 263, 266, 310, 398, 437, 440, 445, 448, 456 Thr 89, 100, 147, 192, 299, 441 Thr 89 4 sites are partially conserved, showing higher potential for phosphorylation. These 15 sites comprise Ser 160, 183, 248, 263, 310, 398, 437, 440, 444, 445, 448, and Thr 73, 89, 219 , and 274 (Figure 4) .
Validity of predicted results
Advancement in bioinformatics has made it possible to evaluate the validity of the predicted posttranslational modifications. If predicted amino acids in specific proteins for particular PTM remain conserved, confidence in the predicted results will be increased. If the sites are not conserved over the period of evolution, the predicted results can be questioned. By applying this strategy, a sequence of human EPO-R was aligned with other mammalian species. Among all the yin-yang sites predicted in EPO-R, Ser 160, 380, and 444 and Thr 89 were fully conserved in mammals, but Thr 147 was present only in humans and absent in all other selected species. Among 17 yin-yang sites that were predicted as false negative sites, 13 were conserved, 2 were semiconserved, and 2 sites showed the conserved substitution as shown in Figure 4 . The impact of a particular amino acid in the close vicinity of potential O-glycosylation site has already been established (Thanka Christlet and Veluraja, 2001 ). The association of favorable residues for glycosylation with predicted sites also validates the proposed results (Table  4) . Around the first predicted yin-yang site (Thr 89), conserved proline residue at both the −4 and +5 positions, conserved alanine at the −2 position, and conserved Ser at +1 and +2 positions were observed. Similarly, Thr 147, a second predicted yin-yang site in the extracellular domain of EPO-R, had Proline at the −2,−3, and +1 positions (Table 4) , which is a pattern of amino acid that favors O-glycosylation. This fact supports Thr 147's potential as a yin-yang site. All other predicted yin-yang sites did not have proline in their vicinity except Thr 89, which has proline at the −4 position. We also found 3 such amino acids in close vicinity of all other false positive and negative yin-yang sites that favor glycosylation.
Discussion
Erythropoietin exerts multiple effects in different organs and tissues (Wang et al., 2014) . In hematopoietic tissues, EPO is involved in the cell cycle progression, proliferation, and differentiation of erythroid progenitor cells. As far as the nonhematopoietic functions of EPO are concerned, EPO not only promotes the proliferation and migration of endothelial cells but it also induces neovascularization. Preclinical studies have shown that EPO also exerts cardioprotective effects (Calvillo et al., 2003; Parsa et al., 2004) . With respect to the central nervous system, both EPO-R and EPO become detectable in the brain of human embryos 5 weeks after conception (Dame et al., 2000) . EPO-R has also been expressed by neurons and astrocytes (Bernaudin et al., 1999; Sugawa et al., 2002) , and on these sites EPO exerts both neuroprotective and neurotrophic effects (Digicaylioglu and Lipton, 2001 ). Thus EPO is involved in a variety of functions. However, mechanisms involved in its multifunctional behavior are poorly characterized. The role of phosphorylation of EPO-R in regulating its function has already been described (Constantinescu et al., 1999) . In the present study, the potential of EPO-R's amino acid residues to be phosphorylated and O-glycosylated was explored. Thirty-four potential sites for phosphorylation and 19 sites for O-glycosylation were found. PTMs might have a role in regulating the EPO-R signaling event that may induce the conformational changes affecting protein's structure and their 3D configuration. The amino acid sequence of protein could be investigated by computerassisted methods for the presence of such signals that are likely to become posttranslationally modified. Therefore, predictions based upon the presence of specific amino acid patterns could become a helpful tool to explore the modifications potential and function of proteins (Droit et al., 2005; Ngounou Wetie et al., 2014) .
Among all known PTMs, the dynamic and regulatory nature of O-glycosylation and phosphorylation allows proteins to carry out multiple functions. The alternating presence of these modifications was observed in many different proteins (Cheng and Hart, 2001; Chou et al., 1995; Medina et al., 1998) . For example, it has been experimentally proved that, in transcription factor Myc, Thr 58 is alternately phosphorylated and glycosylated for its regulation (Kamemura et al., 2002) . These observations led to the formation of the yin-yang hypothesis, which states that there is a complex interplay between O-glycosylation and phosphorylation on similar and/or adjacent amino acids of a protein. Phosphorylation of the EPO-R is a Table 3 . Predicted phosphorylation sites of human EPO-R.
Extracellular
Transmembrane Cytoplasmic Ser 151, 160, 167, 183, 221 248 263, 266, 305, 310, 380, 387, 390, 398, 437, 440, 444, 445, 448, 456 Thr 73, 89, 147, 219 274, 296, 324, 342, 415 Tyr 343,401,443,460,464 Table 4 . Favorable and unfavorable amino acids for glycosylation around the yinyang sites. Amino acid sequences, showing the context of (+) and (-) five residues around the yin-yang sites. Yellow highlighted bold letters represent the yin-yang sites. Residues that favor glycosylation are highlighted in green, unfavorable residues are highlighted in red, and residues that neither hinder nor support glycosylation are highlighted in gray. 
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well observed modification that plays a significant role in the signal transduction and regulation of its action. EPO binding to the EPO-R triggers homodimerization of two EPO-R molecules that allows Jak2 molecules to come closer, and trans-and/or autophosphorylates eight Tyr residues on the cytoplasmic domain of the EPO-R. The phosphorylated Tyr residues can serve as docking sites for recruitment of various proteins, for instance, Ser-homolog Tyr phosphatase 1 and 2, phosphatidylinositol 3 kinase, and signal transducer and activator of transcription 5 (Stat5), leading to their phosphorylation and inducing their corresponding signaling cascade (Constantinescu et al., 1999) . Previously, it was thought that only phosphorylated Tyr residues of cytoplasmic domain of EPO-R are involved in the EPO-induced signaling pathway. However, the finding that non-Tyr residues (e.g., Ser) are also involved in controlling EPO-R signaling opens new directions for exploring the internal mechanisms of EPO action (Yoon and Watowich, 2003) . These researchers suggested the possible involvement of phosphorylated Ser residue (rather Tyr) in stimulating the Stat5 signaling pathway, emphasizing the significance of Ser residues in C-terminal region of EPO-R. However, theses authors did not mention the position of the involved Ser residue(s). We predicted 12 potential Ser residues for phosphorylation (305, 310, 380, 387, 390, 398, 437, 440, 444, 445, 448, and 456) in the C-terminal region EPO-R. Interestingly, all these Ser residues were conserved in mammals, making them possible targets for PTMs (Figure 4 ). Among these, Ser 380 and 444 also showed potential for both phosphorylation and O-glycosylation modification and have been predicted as yin-yang sites. In the C-terminal region, these two sites may play a regulatory role through alternating phosphorylation and O-glycosylation modification.
In the EPO-R cytoplasmic region, another important residue is Ser 478, which showed high potential for O-glycosylation, and its adjacent Tyr 479, which supports the differentiation and proliferation of erythroid progenitor cells in its phosphorylated form. Tyr 479 is a key residue that supports erythroid colony formation without the presence of any other Tyr residues . However, Tyr 479 seems to have limited potential for phosphorylation, as Tyr 479 is highly conserved among mammals and its phosphorylation has also been proven experimentally (Sulahian et al., 2009) . Therefore, this residue appears to be a false negative phosphorylation site. It has been suggested that Tyr 479 in its phosphorylated form is involved in the EPO-dependent EPO-R internalization, and controls the duration of EPO-induced signaling. Controlling the duration of signaling is crucial, as this decides the ultimate final effect of signaling. For example, when EPO receptor signaling was reduced, it decreased cell proliferation and increased the terminal differentiation of erythroid cells (Sulahian et al., 2009) . When Ser 478 is modified by glycosylation, it may block or delay phosphorylation on Tyr 479. This may result in decreased cell proliferation and differentiation, while increased phosphorylation facilitates cell proliferation of erythroid stem cells. This could be a notable example of the interplay between Tyr phosphorylation and O-glycosylation at neighboring residues, which regulates the signaling event induced by EPO. This complex binary switch between Tyr phosphorylation and O-glycosylation modification seems to regulate the signaling event induced by EPO.
A complex network of signaling pathways allows EPO-R to perform multiple functions. However, it is still unclear how the binding of EPO (a single ligand) molecule could affect different organs. EPO-R endocytosis is an efficient way to increase or decrease EPO responsiveness. Endocytosis is a common process of attenuation and downregulation of EPO-R. In addition, EPO-R endocytosis plays a significant role in the clearance of EPO and therefore regulates its bioactivity (Walrafen et al., 2005) . Only one residue (Ser 248) in the transmembrane domain showed potential for phosphorylation. When the amino acids context of Ser 248 was closely analyzed, it had amino acids in its proximity that favor glycosylation. Thus, Ser 248 appears to be an important residue because of its transmembrane position and presence of downstream lysine-rich region. These observations reveal that this residue may potentially play a role in EPO-R endocytosis, degradation, and recycling.
When the sequence of cytoplasmic domain of the EPO-R was further explored, it was observed that Thr 423, which possesses high phosphorylation potential (data predicted through KinasePhos 2.0; not shown), is present near lysine (K 428). The presence of proline at both +1 and −1 positions also supports its glycosylation potential. Glycosylation at Thr 423 might hinder β-TrCP binding, an enzyme involved in regulation of the EPO-R that ubiquitinates at K-428 and ultimately results in recycling EPO-R to the cell surface (Meyer et al., 2007) . However, phosphorylation on the same residue inhibits the EPO-R recycling and decreases EPO sensitivity (Gross and Lodish, 2006) . This internalization and ubiquitination of EPO-R might allow the EPO protein to perform different functions in a different organ by prolonging or shortening the signaling phenomenon. Important evidence that Ser/ Thr phosphorylation plays a significant role in controlling the EPO functions has come from the involvement of protein kinase C in controlling the EPO-R signaling during erythroid differentiation and proliferation. Protein kinase C is a Ser/Thr kinase and its inhibition can reportedly abrogate EPO-dependent mitosis (von Lindern et al., 2000) .
The exact mechanism of controlling EPO-R signaling is not entirely understood. Different aspects still need to be explored. On the basis of these findings and previously available data, we propose the involvement of alternating Ser/Thr O-glycosylation and phosphorylation in controlling EPO-R signaling. As O-glycosylation of EPO-R is essential in increasing its sensitivity to EPO, its phosphorylation at certain residues negates its effects. The interplay between Tyr phosphorylation and O-glycosylation modification of neighboring residues may be involved in controlling the duration of EPO-R signaling. In conclusion, along with Ser/Thr alternative phosphorylation and O-glycosylation, Tyr phosphorylation and its interplay with neighboring glycosylated residues may also play a decisive role in regulating the EPO-R function. These binary modifications may help solve many unanswered mechanisms related to EPO-R ubiquitination, internalization, and recycling and also its multifunctional behavior under different hematopoietic and nonheamatopoietic environments.
